Platelet-derived growth factor (PDGF)- A–deficient male mice were found to develop progressive reduction of testicular size, Leydig cells loss, and spermatogenic arrest. In normal mice, the PDGF-A and PDGF-Rα expression pattern showed positive cells in the seminiferous epithelium and in interstitial mesenchymal cells, respectively. The testicular defects seen in PDGF-A−/− mice, combined with the normal developmental expression of PDGF-A and PDGF-Rα, indicate that through an epithelial-mesenchymal signaling, the PDGF-A gene is essential for the development of the Leydig cell lineage. These findings suggest that PDGF-A may play a role in the cascade of genes involved in male gonad differentiation. The Leydig cell loss and the spermatogenic impairment in the mutant mice are reminiscent of cases of testicular failure in man.

Introduction

The genes involved in the determination of the gonads comprise the Wilms' tumor suppressor gene WT1, the orphan nuclear receptor SF-1 and the high mobility group family member SOX9 (Parker et al. 1999). After determination, the differentiation of the testis depends on the testis-determining factor SRY (Goodfellow and Lovell-Badge 1993). SRY induces the Sertoli cells to differentiate and to secrete the Mullerian inhibiting substance, which suppresses the development of the female reproductive tract (Gustafson and Donahoe 1994). Later, under the influence of Sertoli cells, the Leydig cells develop (Ge et al. 1996). The ontogenesis of Leydig cells involves two distinct cell generations (McLaren 1998). The fetal Leydig cells originate prenatally and produce androgens required for the masculinization during fetal and neonatal life. They regress thereafter and are substituted during puberty by the adult Leydig cells, which supply the testosterone necessary for completion of spermatogenesis and maintenance of male reproductive function. Adult Leydig cells do not derive from preexisting fetal cells but from undifferentiated mesenchymal stem cells (McLaren 1998). The factors that regulate the commitment and early differentiation of stem cells to adult Leydig cell lineage are unknown.

PDGF-A, a high-affinity ligand for the receptor tyrosine kinase PDGF-Rα, is required for embryonic and postnatal development (Betsholtz and Raines 1997). PDGF-A–deficient animals develop lung emphysema secondary to the failure of alveolar septation (Boström et al. 1996), defective oligodendrogenesis (Calver et al. 1998; Fruttiger et al. 1999), and skin and hair defects (Karlsson et al. 1999). Previous studies have revealed that PDGF-A may play a role in testicular development (Gnessi et al. 1995) and that Leydig cells express PDGF-Rα (Gnessi et al. 1992; Loveland et al. 1995). Here we report the testicular phenotype of PDGF-A–deficient mouse generated by targeted gene disruption. From this study, we conclude that PDGF-A is an essential factor for adult Leydig cells development.

Materials and Methods

Animals

PDGF-A null mutant mice, heterozygous, and wild-type (WT) littermates were obtained from heterozygous crosses all bred as 129Ola/C57 B16 hybrids (Boström et al. 1996). Transgenic mice carrying the reporter gene β-galactosidase (lacZ) under control of a 6-kb regulatory domain of the murine PDGF-Rα promoter were generated as previously described (Reinertsen et al. 1997).

In Situ Hybridization

Nonradioactive in situ hybridization using PDGF-A and PDGF-Rα probes was performed as described (Boström et al. 1996).

Histology, Immunohistochemistry, and lacZ Staining

Testes to be stained by periodic acid-Schiff (PAS)/haematoxylin, bromodeoxyuridine (BrdU), TdT-mediated dUTP biotin nick end labeling (TUNEL), PDGF-A, PDGF-Rα, relaxin-like actor (RLF), and GATA-1 immunohistochemistry were fixed in 4% buffered paraformaldehyde and paraffin embedded. The reactions were carried out on 5-μm sections. For routine histology, sections were stained by PAS/haematoxylin according to standard protocols. For BrdU labeling, BrdU (Sigma-Aldrich) was injected intraperitoneally (100 mg/g body mass). Injected animals were killed 2 h later and the fixed testes were processed as described (Karlsson et al. 1999). Apoptotic cells were detected by TUNEL using the ApopTag Plus in situ detection kit (Oncor) according to the instructions of the manufacturer. Sertoli cells were detected using a GATA-1–specific antibody (Santa Cruz Biotechnology); Leydig cells were detected using a rat anti-RLF antibody (generously provided by Professor Richard Ivell, Institute of Hormone and Fertility Research, Hamburg, Germany); PDGF-A and PDGF-Rα–positive cells were detected using rabbit anti-PDGF-A (RDI Inc.) and rat anti-PDGF-Rα (PharMingen) antibodies. The antibodies (anti-GATA1, anti-PDGF-A, and anti-PDGF-Rα at 1:100 dilution; anti-RLF at 1:1,000 dilution) were incubated overnight at 4°C. The avidin-biotin immunoperoxidase system with 3-amino-9-ethylcarbazole as chromogen was used to visualize bound antibodies (Histostain-Plus kit; Zymed Laboratories). For lacZ staining, transgenic animals were fixed and stained with X-gal for lacZ activity, and 10-μm cryostat testicular sections were treated as described (Reinertsen et al. 1997).

Hormone Assays

Serum testosterone and luteinizing hormone (LH) levels were determined by radioimmunoassays using DiaSorin and Amersham assay systems according to the manufacturers' instructions.

Results and Discussion

Newborn PDGF-A−/− mice are outwardly normal but fail to thrive after birth. Most die within a few days, but some individuals survive for as long as 6 wk, eventually dying of pulmonary failure. Due to the lethal phenotype of the homozygous mutants, our analysis was restricted to male mice recovered between postnatal day 10 (P10) and P42, killed before the first signs of respiratory failure were apparent. The heterozygous mice were phenotypically indistinguishable from WT. Surviving null mice weighed less than WT littermates and their growth curve was slower. PDGF-A−/− males had no defects in the external genitalia and testicular descent appeared normal. The testes were reduced in size (Fig. 1 A), however, the testicular size reduction in the mutants was more pronounced than the average reduction of the body size, and this feature increased dramatically with age (Fig. 1 B). Testis histology revealed profound differences between PDGF-A null mice and WT (Fig. 1, C–J). At P10, −/− animals showed absence of tubular lumen whose formation was starting in the controls; no significant difference was observed in tubular diameter and germ cells number. Sertoli cells, interstitial cells, peritubular myoid cells (PMC) and extracellular matrix layers appeared intact as well (Fig. 1C and Fig. D). At P18, the mutant testes had reduced seminiferous tubule diameter and poor lumen formation but, likewise control littermates, spermatogenesis had proceeded up to pachytene spermatocytes; Sertoli cells and PMC were normal. However, the null mice showed an initial reduction in number of morphologically recognizable Leydig cells, scattered in the interstitium among small undifferentiated spindle-shaped mesenchymal cells of fibroblastic appearance (Fig. 1E and Fig. F). At P25, round spermatids were frequently found in the tubules of +/+ animals and the interstitium was filled with Leydig cells; no spermatids and a further reduction of the interstitial cells population were observed in the mutants (data not shown). At P32 and P42 all stages of the spermatogenic cycle and abundant Leydig cells were seen in control testis (Fig. 1G and Fig. I). In −/− P32 testis, the tubular diameter was greatly reduced and a spermatocytic arrest with further loss of Leydig cells was observed (Fig. 1 H). P42−/− testis displayed a dramatic decrease of spermatocytes, adluminal multinucleated giant cells, and an almost complete absence of Leydig cells (Fig. 1 J). Immunostaining of P10-P42−/− testicular sections with an antibody against the Sertoli cell–specific gene GATA-1 (Yomogida et al. 1994) confirmed the presence of Sertoli cells in the null testis, indicating that the lack of mature forms of germ cells in PDGF-A−/− mice did not result from a loss of the supporting cells (data not shown). We also performed an immunohistochemical analysis of RLF, which is a specific marker for the mature forms of fetal as well as adult Leydig cells (Balvers et al. 1998). Anti-RLF staining identified mature fetal Leydig cells in both mutant and WT P10 testis (Fig. 2A and Fig. B). At P18, concomitantly with the involution of fetal Leydig cells and with the first appearance of the adult Leydig cells progenitors, no RLF was expressed in −/− testis while sporadic punctate staining was seen in the interstitium of +/+ testis (Fig. 2C and Fig. D). This trend increased at P25. Here there was no staining in the few interstitial cells of the KO testis, while the majority of the interstitial cells of the WT testis exhibited RLF-specific staining (Fig. 2E and Fig. F). By day 32 and onward, a more homogeneous cytoplasmic distribution of RLF positivity within the interstitial cells of the WT animals was observed while, concomitantly with the progressive depletion of the interstitium, RLF staining in the KO testis was absent (data not shown). This RLF staining pattern indicates that the mutant prepubertal testis contains mature fetal Leydig cells and confirms the absence of the adult Leydig cell population in older −/− testis.

To analyze whether the reduced size of the PDGF-A mutant testis and its histologic appearance could be due to decreased cell proliferation and/or increased apoptosis, BrdU and TUNEL labeling were performed. At P18, P25, P32, and P42 there was no difference in BrdU incorporation of the actively proliferating germ cells between WT and mutant testes (Fig. 3, A–D; data not shown). During the third week of postnatal life, the stem cell precursors of the adult Leydig cell proliferate (Ge et al. 1996). Accordingly, BrdU staining was observed in some interstitial cells of P18 WT animals (Fig. 3 A); on the contrary, no BrdU labeling was seen in P18 PDGF-A−/− littermates (Fig. 3 B). Regarding TUNEL, few apoptotic cells were seen in the tubules of both WT and −/− siblings between P10 and P32 (data not shown). However, at P42 a large number of spermatocytes undergoing apoptosis was observed in null mice compared with control (Fig. 3E and Fig. F). No evidence for apoptosis-mediated death of other testicular cell types was seen. Thus, an arrest of differentiation followed by increased apoptosis seem to be responsible for the seminiferous tubules aspect in the PDGF-A−/− testes. The lack of BrdU incorporation and the absence of TUNEL labeling in the intertitium of −/− testis, indicate that the paucity of Leydig cells might be due to a proliferative arrest. Thus, we speculate that in the PDGF-A−/− testis the normal pubertal replacement of the fetal Leydig cells with the adult population of cells is deranged because of a deficiency in the commitment of the adult Leydig cell precursors to proliferate and perhaps to differentiate.

Such a model requires the knowledge of the localization of PDGF-A and its receptor in normal testis. In situ hybridization for PDGF-A and PDGF-Rα in embryonic-day-17.5 (E17.5)-P30 WT testis showed the mRNAs expression in seminiferous epithelium and interstitial mesenchymal cells, respectively (Fig. 4, A–H). At E17.5 the PDGF-A and PDGF-Rα labeling was rather homogeneous. Later, some PDGF-A–positive tubules and distinct populations of PDGF-Rα–positive interstitial cells could be seen. PDGF-Rα expression was moreover localized using transgenic mice carrying the reporter gene β-galactosidase (lacZ) under control of the murine PDGF-Rα promoter. According to the in situ data, lacZ staining was found in the interstitium (Fig. 4I and Fig. J). The immunohistochemistry for PDGF-A confirmed the intratubular expression of the growth factor which, in agreement with previous results (Gnessi et al. 1992, Gnessi et al. 1995; Loveland et al. 1995), was mainly localized in the cytoplasm of the Sertoli cells (Fig. 5). At P18, although with different intensities, all the tubules were stained (Fig. 5 A). At P42, in line with the in situ findings, only the Sertoli cells in some tubules, corresponding to spermatogenic stages IX-X (Russell et al. 1990), were positive (Fig. 5 B). Altogether, these results indicate that the PDGF-A expression in Sertoli cells depends on the stage of maturation of the associated germ cells. At P42, a weak signal was also found in some interstitial cells (Fig. 5 B), which is consistent with the reported production of PDGF-A by adult Leydig cells in vitro (Gnessi et al. 1992, Gnessi et al. 1995; Loveland et al. 1995). Concerning PDGF-Rα, in prepubertal animals the immunostaining was localized in the interstitial cells of both +/+ and −/− testis, although in the latter the interstitial cells were less in number (Fig. 5C and Fig. D). In older animals, the WT testis continued to show PDGF-Rα–positive cells between the tubules (Fig. 5 E), while the null testis showed a steadily decreasing number of positive cells, culminating in their complete absence at P42 (Fig. 5 F). The comparison between the testicular defects found in −/− mice and the normal expression pattern of PDGF-A and its receptor, indicates that paracrine PDGF-A/PDGF-Rα signaling constitutes a critical part of the epithelial-mesenchymal interaction, essential for adult Leydig cells development. PDGF-A does not influence the fetal generation of Leydig cells, as suggested by both the normal adrogenization and RLF-positive interstitial immunohistochemical staining of prepubertal −/− animals. Due to the lack of specific markers, we could not produce direct evidence that among the interstitial PDGF-Rα–positive cells are indeed the precursors of the adult Leydig cells, but the spatiotemporal distribution of PDGF-Rα-interstitial cells in normal mice seems to suggest this possibility. It is also reasonable to predict that a cell type specifically lost in PDGF-A−/− mice should carry the receptor for PDGF-A, and should locate close to the source of the ligand, as is the case for the PDGF-Rα–positive interstitial mesenchymal cells described. However, given the chemotactic activity of PDGF-A (Heldin and Westermark 1999), we cannot exclude that, similarly to what is described for other PDGF-dependent developmental processes (Boström et al. 1996; Lindahl et al. 1997a,Lindahl et al. 1997b; Calver et al. 1998), PDGF-A might influence the long-range migration of Leydig stem cells, thus preventing their arrival in the gonads from primordial germ layer source besides proliferation and differentiation.

Regardless of whether PDGF-A influences the migration of the Leydig cells precursors or their proliferation/differentiation, the main consequence of the lack of replacement of the fetal Leydig cells with adult cells would be a progressive reduction of testosterone, followed by spermatogenic arrest and germ cells degeneration. The testicular phenotype of the null animals strongly indicates that this is the case. In −/− testis the initiation of spermatogenesis, which depends mainly on follicle-stimulating hormone, occurs normally, while its testosterone-dependent subsequent completion and maintenance (Sharpe 1994) are lacking. Indeed, serum testosterone levels were similar in prepubertal/early pubertal (P10-P18) WT (1.79 ± 0.7 ng/ml; n = 5) and mutant mice (2.0 ± 0.89 ng/ml; n = 3), while in −/− older animals, circulating testosterone was not detectable, confirming that the spermatogenic arrest and germ line apoptotic regression in PDGF-A−/− animals are mediated by androgen deficiency.

The plasma levels of luteinizing hormone (LH) were also measured. They were similar in −/− (1.6 ± 0.4 ng/ml; n = 4) and +/+ (1.4 ± 0.5 ng/ml; n = 6) animals between P10 and P25. In agreement with the testosterone reduction, in a null P42 animal the levels of LH (7.5 ng/ml) were higher than in control littermates (3.8 ± 0.3 ng/ml; n = 4). These data indicate that in PDGF-A null animals, the fate of the Leydig cells cannot be ascribed to an LH deficiency.

In conclusion, understanding of Leydig cell development is still incomplete. Although LH, androgens and IGF-1 are recognized important elements required for the completion of Leydig cell maturation, they cannot be the factors that regulate the commitment of stem cells to adult Leydig cell lineage (Benton et al. 1995). In fact, initial proliferation of stem cells can occur when LH is absent (Teerds et al. 1989), and animals with androgen insensitivity (Murphy et al. 1994) or IGF-1 gene deletion (Baker et al. 1996) develop Leydig cells, suggesting that a separate factor regulates the earliest stage of adult Leydig cell evolution. Our findings indicate that PDGF-A may be this factor, and suggest that adult Leydig cells arise from PDGF-Rα progenitors.

The pivotal role played by PDGF-A in adult Leydig cells development suggests that PDGF-A may be a potential target for the master genes involved in testicular organogenesis. In this respect, it is worth mentioning that WT1, whose spatio-temporal Sertoli cells expression profile (Pelletier et al. 1991; Mundlos et al. 1993; Rackley et al. 1993; Del Rio-Tsonis et al. 1996) is virtually superimposable on that of PDGF-A, can either repress or activate the PDGF-A gene (Wang et al. 1992, Wang et al. 1993a, Wang et al. 1993b; Gashler et al., 1992), and has been involved in posttranscriptional processing within the Sertoli cells (Larsson et al. 1995). The dramatic testicular phenotype of the PDGF-A−/− animals is also of interest because recent studies have reported detection of PDGF-A and PDGF-Rα in the human testis (Basciani, S., L. Gnessi, M. Arizzi, N. Rucci, S. Mariani, S. Ulisse, E.A. Jannini, G. Spera. 1999. Proceedings of the 81st Annual Meeting of the Endocrine Society, San Diego, CA. Abst. P2–P81). These considerations, coupled with our findings, may furnish a new approach for the understanding of the WT1-mediated mechanisms involved in testicular development and perhaps of WT1-dependent urogenital abnormalities and tumorigenesis (Hastie 1994; Reddy and Licht 1996; Menke et al. 1998). Moreover, a local impairment of the PDGF-A/ PDGF-Rα system may provide a new conceptual framework for the comprehension of some forms of Leydig cells hypoplasia, with high LH, low testosterone, and no mutations of the LH receptor gene (Zenteno et al. 1999), and of cases of spermatogenetic failure, which are probably due to intratesticular testosterone deficiency in man (Sharpe 1994).

Acknowledgments

We thank Marella Maroder, Giuseppe Giannini, and Andrea Fabbri for critical reading of the manuscript, S. Beckman for excellent handling of the mutant mouse breeding programs, and W. Richardson for DNA probe.

The study was supported by grants from the Italian MURST progetti di ricerca di Ateneo (ex quota 60%), the Swedish Cancer Foundation, the Swedish Medical Research Council, the Göran Gustafsson Foundation, the Inga-Britt and Arne Lundberg Foundation, and National Institutes of Health grants CA-74907 and NS-36366. S. Basciani and S. Mariani are recipient of a postdoctoral fellowship of the University of Rome “La Sapienza”.

References

References
Baker
J.
,
Hardy
M.P.
,
Zhou
J.
,
Bondy
C.
,
Lupu
F.
,
Bellve
A.R.
,
Efstratiadis
A.
Effect of an IGF1 gene null mutation on mouse reproduction
Mol. Endocrinol.
10
1996
903
918
[PubMed]
Balvers
M.
,
Spiess
A.-N.
,
Domagalaski
R.
,
Hunt
N.
,
Kilic
E.
,
Mukhopadhyay
A.K.
,
Hanks
E.
,
Charlton
H.M.
,
Ivell
R.
Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary
Endocrinology.
139
1998
2960
2970
[PubMed]
Benton
L.
,
Shan
L.-X.
,
Hardy
M.P.
Differentiation of adult Leydig cells
J. Steroid Biochem. Mol. Biol.
53
1995
61
68
[PubMed]
Betsholtz
C.
,
Raines
E.W.
Platelet-derived growth factora key regulator of connective tissue cells in embryogenesis and pathogenesis
Kidney Int.
51
1997
1361
1369
[PubMed]
Boström
H.
,
Willetts
K.
,
Pekny
M.
,
Leveen
P.
,
Lindahl
P.
,
Hedstrand
H.
,
Pekna
M.
,
Hellstrom
M.
,
Gebre-Medhin
S.
,
Schalling
M.
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis
Cell.
85
1996
863
873
[PubMed]
Calver
A.R.
,
Hall
A.C.
,
Yu
W.P.
,
Walsh
F.S.
,
Heath
J.K.
,
Betsholtz
C.
,
Richardson
W.D.
Oligodendrocyte population dynamics and the role of PDGF in vivo
Neuron.
20
1998
869
882
[PubMed]
Del Rio-Tsonis
K.
,
Covarrubias
L.
,
Kent
J.
,
Hastie
N.D.
,
Tsonis
P.A.
Regulation of the Wilms' tumor gene during spermatogenesis
Dev. Dyn
207
1996
372
381
[PubMed]
Fruttiger
M.
,
Karlsson
L.
,
Hall
A.C.
,
Abramsson
A.
,
Calver
A.R.
,
Bostrom
H.
,
Willetts
K.
,
Bertold
C.-H.
,
Heath
J.K.
,
Betsholtz
C.
,
Richardson
W.D.
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice
Development.
126
1999
457
467
[PubMed]
Gashler, A.L., D.T. Bonthron, S.L. Madden, F.J.J. Rauscher 3rd, T. Collins, and V.P. Sukhatme. 1992. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc. Natl. Acad. Sci. USA. 89:10984–10988.
Ge
R.-S.
,
Shan
L.-X.
,
Hardy
M.P.
,
Pubertal development of Leydig cells
Payne
A.
,
Hardy
M.P.
,
Russell
L.D.
The Leydig cell
1996
159
173
Cache River Press
Vienna, IL
Gnessi
L.
,
Emidi
A.
,
Farini
D.
,
Scarpa
S.
,
Modesti
A.
,
Ciampani
T.
,
Silvestroni
L.
,
Spera
G.
Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules
Endocrinology.
130
1992
2219
2224
[PubMed]
Gnessi
L.
,
Emidi
A.
,
Jannini
E.A.
,
Carosa
E.
,
Maroder
M.
,
Arizzi
M.
,
Ulisse
S.
,
Spera
G.
Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action
J. Cell Biol.
131
1995
1105
1121
[PubMed]
Goodfellow
P.N.
,
Lovell-Badge
R.
SRY and sex determination in mammals
Annu. Rev. Genet.
27
1993
71
92
[PubMed]
Gustafson
M.L.
,
Donahoe
P.K.
Male sex determinationcurrent concepts of male sexual differentiation
Annu. Rev. Med.
45
1994
505
524
[PubMed]
Hastie
N.D.
The genetics of Wilms' tumor a case of disrupted development
Annu. Rev. Genet
28
1994
523
558
[PubMed]
Heldin
C.-H.
,
Westermark
B.
Mechanism of action and in vivo role of platelet-derived growth factor
Physiol. Rev
79
1999
1283
1316
[PubMed]
Karlsson
L.
,
Bondjers
C.
,
Betsholtz
C.
Roles for PDGF-A and sonic hedgehog in development of mesenchymal components of the hair follicle
Development.
126
1999
2611
2621
[PubMed]
Larsson
S.H.
,
Charlieu
J.P.
,
Miyagawa
K.
,
Engelkamp
D.
,
Rassoulzadegan
M.
,
Ross
A.
,
Cuzin
F.
,
van Heyningen
V.
,
Hastie
H.D.
Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing
Cell.
81
1995
391
401
[PubMed]
Lindahl
P.
,
Johansson
B.
,
Levéen
P.
,
Betsholtz
C.
Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
Science.
277
1997
242
245
a
[PubMed]
Lindahl
P.
,
Karlsson
L.
,
Hellstrom
M.
,
Gebre-Medhin
S.
,
Willetts
K.
,
Heath
J.K.
,
Betsholtz
C.
Alveogenesis failure in PDGF-A–deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development
Development.
124
1997
3943
3953
b
[PubMed]
Loveland
K.L.
,
Zlati
K.
,
Stein-Oakley
A.
,
Risbridger
G.
,
de Kretser
D.M.
Platelet-derived growth factor ligand and receptor subunit mRNA in the Sertoli and Leydig cells of the rat testis
Mol. Cell. Endocrinol.
108
1995
155
159
[PubMed]
McLaren
A.
Gonad developmentassembling the mammalian testis
Curr. Biol
8
1998
R175
R177
[PubMed]
Menke
A.L.
,
van der Eb
A.J.
,
Jochemsen
A.G.
The Wilms' tumor 1 geneoncogene or tumor suppressor gene?
Int. Rev. Cytol
181
1998
151
212
[PubMed]
Mundlos
S.
,
Pelletier
J.
,
Darveau
A.
,
Bachmann
M.
,
Winterpacht
A.
,
Zabel
B.
Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues
Development.
119
1993
1329
1341
[PubMed]
Murphy
L.
,
Jeffcoate
I.A.
,
O'Shaughnessy
P.J.
Abnormal Leydig cell development at puberty in the androgen-resistant Tfm mouse
Endocrinology.
135
1994
1372
1377
[PubMed]
Parker
K.L.
,
Shendl
A.
,
Schimmer
B.P.
Gene interactions in gonadal development
Annu. Rev. Physiol.
61
1999
417
433
[PubMed]
Pelletier
J.
,
Schalling
M.
,
Buckler
A.J.
,
Rogers
A.
,
Haber
D.A.
,
Housman
D.
Expression of the Wilms' tumor gene WT1 in the murine urogenital system
Genes Dev
5
1991
1345
1356
[PubMed]
Rackley
R.R.
,
Flenniken
A.M.
,
Kuriyan
N.P.
,
Kessler
P.M.
,
Stoler
M.H.
,
Williams
B.R.
Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis
Cell. Growth Differ.
4
1993
1023
1031
[PubMed]
Reddy
J.C.
,
Licht
J.D.
The WT1 Wilms' tumor suppressor genehow much do we really know?
Biochim. Biophys. Acta.
1287
1996
1
28
[PubMed]
Reinertsen
K.K.
,
Bronson
R.T.
,
Stiles
C.D.
,
Wang
C.
Temporal and spatial specificity of PDGF α receptor promoter in transgenic mice
Gene Expr.
6
1997
301
314
[PubMed]
Russell
L.D.
,
Ettlin
R.A.
,
Sinha-Hikim
A.P.
,
Clegg
E.D.
Histological and Histopathological Evaluation of the Testis
1990
Cache River Press
Clearwater, FL
pp. 286 pp
Sharpe
R.M.
,
Regulation of spermatogenesis
Knobil
E.
,
Neill
J.D.
The Physiology of Reproduction
1994
1363
1434
Raven Press
New York
Teerds
K.J.
,
de Rooij
D.G.
,
Rommerts
F.F.G.
,
van den Hurk
R.
,
Wensing
C.J.G.
Stimulation of the proliferation and differentiation of Leydig cells precursors after the destruction of existing Leydig cells with ethane dimethyl sulphonate (EDS) can take place in the absence of LH
J. Androl.
10
1989
472
477
[PubMed]
Wang
Z.Y.
,
Madden
S.L.
,
Deuel
T.F.
,
Rauscher
F.J.
III.
The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene
J. Biol. Chem
267
1992
21999
22002
[PubMed]
Wang
Z.Y.
,
Qiu
Q.-Q.
,
Deuel
T.F.
The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains
J. Biol. Chem
268
1993
9172
9175
a
[PubMed]
Wang
Y.
,
Qiu
Q.-Q.
,
Enger
K.T.
,
Deuel
T.F.
A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1
Proc. Natl. Acad. Sci. USA.
90
1993
8896
8900
b
[PubMed]
Yomogida
K.
,
Ohtani
H.
,
Harigae
H.
,
Ito
E.
,
Nishimune
Y.
,
Engel
J.D.
,
Yamamoto
M.
Developmental stage- and spermatogenic cycle-specific expression of transcription factor GATA-1 in mouse Sertoli cells
Development.
120
1994
1759
1766
[PubMed]
Zenteno
J.C.
,
Canto
P.
,
Kofman-Alfaro
S.
,
Mendez
J.P.
Evidence for genetic heterogeneity in male pseudohermaphroditism due to Leydig cell hypoplasia
J. Clin. Endocrinol. Metab
84
1999
3803
3806
[PubMed]

Abbreviations used in this paper: BrdU, bromodeoxyuridine; LH, luteinizing hormone; PAS, periodic acid-Schiff; PMC, peritubular myoid cells; RLF, relaxin-like factor; TUNEL, TdT-mediated dUTP biotin nick end labeling; WT, wild-type.